title: [Control of cardiovascular risk factors among patients with diabetes with and without cardiovascular disease].
abstract: BACKGROUND
  There is evidence that cardiovascular goals are beneficial in diabetes.
  
  
  OBJECTIVE
  To determine the distribution of cardiovascular risk levels in patients with diabetes and the clinical interventions they have received.
  
  
  METHODS
  Descriptive cross-sectional study.
  
  
  METHODS
  SERMAS (Madrid) 2010.
  
  
  METHODS
  All patients with diabetes. (n=41,096).
  
  
  METHODS
  Patients in primary or secondary prevention, metabolic and cardiovascular risk factors control, pharmacological and non-pharmacological interventions. Patient and professional variables.
  
  
  RESULTS
  Around one-fifth (21.5%) (95%CI: 21.1% -21.9%) in secondary prevention (very high cardiovascular risk). HbA1c was under control in 31% (95%CI: 30.1%-32%), with 49.9% (95%CI: 48.8%-50.9%) with BP under control, and 39.4% (95% CI: 38.4%-40.4%) with LDL controlled. Only 8.9% (95%CI: 8.3%-9.5%) had a well-controlled HdA1c, BP and LDL, and in 19.8% (95%CI: 19%-20.6%) none of these were under control. Of those with an uncontrolled BP, 23.6% (95% CI: 23.2%-24%) had antihypertensive drugs. There was better control in patients older than 70 years, and those who lived in an urban center, or a lower number of patients per day.
  
  
  CONCLUSIONS
  In diabetic patients with very high cardiovascular risk (secondary prevention), just half of them had good control of cardiovascular risk factors (BP and LDL). An association was found between better control and older than 70, urban center or lower number of patients per day. This suggests developing strategies to promote a comprehensive control of cardiovascular risk factors in diabetic patients in secondary prevention.
authors.affiliation: Centro de Salud Federica Montseny, Servicio Madrileño de Salud, Madrid, España. Electronic address: ana_herrero85@hotmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Herrero
authors.affiliation: Centro de Salud Federica Montseny, Servicio Madrileño de Salud, Madrid, España.
authors.forename: G
authors.initials: G
authors.lastname: Garzón
authors.affiliation: Departamento de Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España.
authors.forename: A
authors.initials: A
authors.lastname: Gil
authors.affiliation: Centro de Salud Federica Montseny, Servicio Madrileño de Salud, Madrid, España.
authors.forename: I
authors.initials: I
authors.lastname: García
authors.affiliation: Centro de Salud Federica Montseny, Servicio Madrileño de Salud, Madrid, España.
authors.forename: E
authors.initials: E
authors.lastname: Vargas
authors.affiliation: Centro de Salud Federica Montseny, Servicio Madrileño de Salud, Madrid, España.
authors.forename: N
authors.initials: N
authors.lastname: Torres
mesh_terms: D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D011322:Primary Prevention / Q000379:methods; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods
chemical_list: D000959:Antihypertensive Agents
keywords: Cardiovascular risk; Diabetes mellitus; Prevención secundaria; Riesgo cardiovascular; Secondary prevention